Table 4
(continued)
Nanomaterial
Aptamer
Target
Drug
Possible application
Reference
Mesoporous silica
nanoparticle
EpCAM aptamer
EpCAM
Doxorubicin
Colon cancer treatment
[109]
Mesoporous silica
nanoparticle
ATP aptamer
ATP
Dye (model)
ATP-responsive controlled
release of drugs
[103]
Mesoporous silica
nanoparticle
ATP aptamer
ATP
Fluorescein (model)
ATP-responsive controlled
release of drugs
[105]
Dendrigraft poly-Llysine (DGL)
AS1411; cytochrome c
aptamer; ATP aptamer
Nucleolin; cytochrome C
and ATP
Doxorubicin
Treatment of multidrugresistant cancer cells
[106]
MS2 bacteriophage
capsid
G-quadruplex targeting
aptamer
MCF-7 cells
Porphyrins for PDT
Breast cancer treatment
[107]
174
A. Eilers et al.
(continued)
Nanomaterial
Aptamer
Target
Drug
Possible application
Reference
Mesoporous silica
nanoparticle
EpCAM aptamer
EpCAM
Doxorubicin
Colon cancer treatment
[109]
Mesoporous silica
nanoparticle
ATP aptamer
ATP
Dye (model)
ATP-responsive controlled
release of drugs
[103]
Mesoporous silica
nanoparticle
ATP aptamer
ATP
Fluorescein (model)
ATP-responsive controlled
release of drugs
[105]
Dendrigraft poly-Llysine (DGL)
AS1411; cytochrome c
aptamer; ATP aptamer
Nucleolin; cytochrome C
and ATP
Doxorubicin
Treatment of multidrugresistant cancer cells
[106]
MS2 bacteriophage
capsid
G-quadruplex targeting
aptamer
MCF-7 cells
Porphyrins for PDT
Breast cancer treatment
[107]
174
A. Eilers et al.
